Scientific article

Allergologie : Omalizumab dans le traitement de l'urticaire chronique : quoi de neuf en 2013 ?

Published inRevue médicale suisse, vol. 10, no. 412-413, p. 18-23
Publication date2014

In 2013, new crucial data dealing with the treatment options for chronic idiopathic and physical urticaria have been published. In this article, after a short introduction where we discuss the classification and the pathogenesis of the disease, we will focus on the therapeutic approach in patients with chronic urticaria. In particular, considering the data available on the treatment with omalizumab, we will discuss the indications and treatment modalities of chronic urticaria.

  • Antibodies, Anti-Idiotypic/therapeutic use
  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Chronic Disease
  • Dermatology/methods/trends
  • Humans
  • Treatment Outcome
  • Urticaria/drug therapy
Citation (ISO format)
SPOERL, David, HARR, Thomas, SEEBACH, Jorg Dieter. Allergologie : Omalizumab dans le traitement de l’urticaire chronique : quoi de neuf en 2013 ? In: Revue médicale suisse, 2014, vol. 10, n° 412-413, p. 18–23.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation12/15/2014 3:50:00 PM
First validation12/15/2014 3:50:00 PM
Update time03/14/2023 10:29:23 PM
Status update03/14/2023 10:29:23 PM
Last indexation01/16/2024 3:17:36 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack